alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › semaglutide-ameliorates

semaglutide-ameliorates

2 studies tagged semaglutide-ameliorates, dated 2025-01-26 to 2026-05-13. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Semaglutide ameliorates neuroinflammation and cognitive impairment in APP/PS1 mice 2026-05-13
  2. The GLP-1 agonist semaglutide ameliorates cognitive regression in P301S tauopathy mice model via autophagy/ACE2/SIRT1/FOXO1-Mediated Microglia Polarization 2025-01-26

Studies

2 studies carry this tag.

Date range

2025 to 2026

Top journals

  • European journal of pharmacology 1
  • Molecular and cellular biochemistry 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Semaglutide ameliorates neuroinflammation and cognitive impairment in APP/PS1 mice

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Molecular and cellular biochemistry 2026-05-13 Drug development

    Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline.

  2. The GLP-1 agonist semaglutide ameliorates cognitive regression in P301S tauopathy mice model via autophagy/ACE2/SIRT1/FOXO1-Mediated Microglia Polarization

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. European journal of pharmacology 2025-01-26 Drug development

    Tau hyper-phosphorylation has been recognized as an essential contributor to neurodegeneration in Alzheimer's disease (AD) and related tauopathies.

All topic tags with their study counts